BACKGROUND: The population-based HIV impact assessment (population-based HIV impact assessments) surveys are among the first to estimate national adult HIV incidence, subnational prevalence of viral load suppression, and pediatric HIV prevalence. We summarize the survey methods implemented in Zimbabwe, Malawi, and Zambia, as well as response rates and quality metrics. METHODS: Each cross-sectional, household-based survey used a 2-stage cluster design. Survey preparations included sample design, questionnaire development, tablet programming for informed consent and data collection, community mobilization, establishing a network of satellite laboratories, and fieldworker training. Interviewers collected demographic, behavioral, and clinical information using tablets. Blood was collected for home-based HIV testing and counseling (HBTC) and point-of-care CD4+ T-cell enumeration with results immediately returned. HIV-positive blood samples underwent laboratory-based confirmatory testing, HIV incidence testing, RNA polymerase chain reaction (viral load), DNA polymerase chain reaction (early infant diagnosis), and serum antiretroviral drug detection. Data were weighted for survey design, and chi square automatic interaction detection-based methods were used to adjust for nonresponse. RESULTS: Each survey recruited a nationally representative, household-based sample of children and adults over a 6-10-month period in 2015 and 2016. Most (84%-90%) of the 12,000-14,000 eligible households in each country participated in the survey, with 77%-81% of eligible adults completing an interview and providing blood for HIV testing. Among eligible children, 59%-73% completed HIV testing. Across the 3 surveys, 97.8% of interview data were complete and had no errors. CONCLUSION: Conducting a national population-based HIV impact assessment with immediate return of HIV and other point-of-care test results was feasible, and data quality was high.
BACKGROUND: The population-based HIV impact assessment (population-based HIV impact assessments) surveys are among the first to estimate national adult HIV incidence, subnational prevalence of viral load suppression, and pediatric HIV prevalence. We summarize the survey methods implemented in Zimbabwe, Malawi, and Zambia, as well as response rates and quality metrics. METHODS: Each cross-sectional, household-based survey used a 2-stage cluster design. Survey preparations included sample design, questionnaire development, tablet programming for informed consent and data collection, community mobilization, establishing a network of satellite laboratories, and fieldworker training. Interviewers collected demographic, behavioral, and clinical information using tablets. Blood was collected for home-based HIV testing and counseling (HBTC) and point-of-care CD4+ T-cell enumeration with results immediately returned. HIV-positive blood samples underwent laboratory-based confirmatory testing, HIV incidence testing, RNA polymerase chain reaction (viral load), DNA polymerase chain reaction (early infant diagnosis), and serum antiretroviral drug detection. Data were weighted for survey design, and chi square automatic interaction detection-based methods were used to adjust for nonresponse. RESULTS: Each survey recruited a nationally representative, household-based sample of children and adults over a 6-10-month period in 2015 and 2016. Most (84%-90%) of the 12,000-14,000 eligible households in each country participated in the survey, with 77%-81% of eligible adults completing an interview and providing blood for HIV testing. Among eligible children, 59%-73% completed HIV testing. Across the 3 surveys, 97.8% of interview data were complete and had no errors. CONCLUSION: Conducting a national population-based HIV impact assessment with immediate return of HIV and other point-of-care test results was feasible, and data quality was high.
Authors: Jessica Justman; Jason B Reed; George Bicego; Deborah Donnell; Keala Li; Naomi Bock; Alison Koler; Neena M Philip; Charmaine K Mlambo; Bharat S Parekh; Yen T Duong; Dennis L Ellenberger; Wafaa M El-Sadr; Rejoice Nkambule Journal: Lancet HIV Date: 2016-11-16 Impact factor: 12.767
Authors: Wanjiru Waruiru; Andrea A Kim; Davies O Kimanga; James Ng'ang'a; Sandra Schwarcz; Lucy Kimondo; Anne Ng'ang'a; Mamo Umuro; Mary Mwangi; James K Ojwang'; William K Maina Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Suzue Saito; Yen T Duong; Melissa Metz; Kiwon Lee; Hetal Patel; Katrina Sleeman; Julius Manjengwa; Francis M Ogollah; Webster Kasongo; Rick Mitchell; Owen Mugurungi; Frank Chimbwandira; Crispin Moyo; Vusumuzi Maliwa; Helecks Mtengo; Tepa Nkumbula; Clement B Ndongmo; Nora Skutayi Vere; Geoffrey Chipungu; Bharat S Parekh; Jessica Justman; Andrew C Voetsch Journal: J Int AIDS Soc Date: 2017-11 Impact factor: 5.396
Authors: George T Bicego; Rejoice Nkambule; Ingrid Peterson; Jason Reed; Deborah Donnell; Henry Ginindza; Yen T Duong; Hetal Patel; Naomi Bock; Neena Philip; Cherry Mao; Jessica Justman Journal: PLoS One Date: 2013-10-15 Impact factor: 3.240
Authors: Anna Bershteyn; Lise Jamieson; Hae-Young Kim; Ingrida Platais; Masabho P Milali; Edinah Mudimu; Debra Ten Brink; Rowan Martin-Hughes; Sherrie L Kelly; Andrew N Phillips; Loveleen Bansi-Matharu; Valentina Cambiano; Paul Revill; Gesine Meyer-Rath; Brooke E Nichols Journal: Lancet Glob Health Date: 2022-09 Impact factor: 38.927
Authors: Shannon M Farley; Chunhui Wang; Rachel M Bray; Andrea Jane Low; Stephen Delgado; David Hoos; Angela N Kakishozi; Tiffany G Harris; Rose Nyirenda; Nellie Wadonda; Michelle Li; Mbaraka Amuri; James Juma; Nzali Kancheya; Ismela Pietersen; Nicholus Mutenda; Salomo Natanael; Appolonia Aoko; Evelyn W Ngugi; Fred Asiimwe; Shirley Lecher; Jennifer Ward; Prisca Chikwanda; Owen Mugurungi; Brian Moyo; Peter Nkurunziza; Dorothy Aibo; Andrew Kabala; Sam Biraro; Felix Ndagije; Godfrey Musuka; Clement Ndongmo; Judith Shang; Emily K Dokubo; Laura E Dimite; Rachel McCullough-Sanden; Anne-Cecile Bissek; Yimam Getaneh; Frehywot Eshetu; Tepa Nkumbula; Lyson Tenthani; Felix R Kayigamba; Wilford Kirungi; Joshua Musinguzi; Shirish Balachandra; Eugenie Kayirangwa; Ayiyi Ayite; Christine A West; Stephane Bodika; Katrina Sleeman; Hetal K Patel; Kristin Brown; Andrew C Voetsch; Wafaa M El-Sadr; Jessica J Justman Journal: J Int AIDS Soc Date: 2022-09 Impact factor: 6.707
Authors: Christine A West; Gregory C Chang; Dustin W Currie; Rachel Bray; Steve Kinchen; Stephanie Behel; Rachel McCullough-Sanden; Andrea Low; Anne Bissek; Judith D Shang; Clement B Ndongmo; Emily K Dokubo; Shirish Balachandra; Legre R Lobognon; Lenhle Dube; Harriet Nuwagaba-Biribonwoha; Michelle Li; Munyaradzi Pasipamire; Yimam Getaneh; Sileshi Lulseged; Frehywot Eshetu; Leonard Kingwara; Emily Zielinski-Gutierrez; Mphotleng Tlhomola; Puleng Ramphalla; Thokozani Kalua; Andrew F Auld; Daniel B Williams; Eric Remera; Gallican N Rwibasira; Veronicah Mugisha; Samuel S Malamba; Jeremiah Mushi; Mohamed F Jalloh; George S Mgomella; Wilford L Kirungi; Sam Biraro; Anna C Awor; Danielle T Barradas; Owen Mugurungi; John H Rogers; Megan Bronson; Stephane M Bodika; Aderonke Ajiboye; Nicholas Gaffga; Carole Moore; Hetal K Patel; Andrew C Voetsch Journal: J Acquir Immune Defic Syndr Date: 2021-08-01 Impact factor: 3.771